gip and glp 1 receptors LY3437943, a novel triple glucagon, GIP, GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept Beyond the pancreas: contrasting cardiometabolic

This is not a semantic distinction, since confirming the primary site will dictate the patients clinical stage and the type of therapy they will undergo

Neuronal energy is primarily supplied by bloodderived glucose and its metabolite lactate, whereas astrocytes provide a major buffering node through glycogen mobilization during hypoglycemia and are widely regarded as the predominant site of fatty acid oxidation in the adult brain (Morant-Ferrando et al., 2023)

It also aligns with the observed improvements in cardiometabolic markers seen in clinical trials of incretin-based therapies

Is your organization looking for a scalable, science-based way to address obesity and cardiometabolic disease

Gastrointestinal Tissue Research BPC-157 is derived from a gastric protein fragment and is investigated in preclinical GI models for how it may influence mucosal signaling, inflammatory pathway modulation, and cellular proliferation